Clorox (NYSE:CLX) published its first-quarter fiscal 2027 results after market close on Monday. At first glance, the company's growth rates looked enormously impressive. A closer read of the numbers reveals its performance wasn't so sparkling. This dynamic raises a big question, particularly for income investors of this high-yield dividend payer: is Clorox a buy, given how it did in the quarter? Image source: Getty Images.
CryptoAlerta — análise de criptomoedas e mercado em tempo real